Kim McCleary is managing director at FasterCures, leading the charge on key programmatic areas including FDA and how it evaluates risk and benefit for patients, and medical innovation and how we determine value and reimbursement.
She was most recently with the CFIDS Association of America, where she was the president and CEO from 1991 until June 2013. McCleary earned a reputation as an articulate patient advocate, a keen policy strategist, a diplomatic bridge builder and a dedicated servant leader. She has worked with leaders throughout the executive and legislative branches to develop, implement and oversee effective policy.
She helped found the Chronic Pain Research Alliance and joined with other leaders and Pfizer to establish the Campaign to End Women's Pain in 2010. McCleary led the Partnering to End Pain project selected by Sanofi U.S. as a finalist in the 2012 Collaborate Activate Innovation Challenge. She has participated in every opportunity organized by the FDA to shape its Patient-Focused Drug Development Initiative, including a range of consultations leading up the first of the 20 PFDDI workshops focused on CFS and ME held in April 2013. With leaders in the narcolepsy community, McCleary helped design and launch the Unite Narcolepsy initiative to educate, engage and empower narcolepsy patients and their advocates to participate effectively in the PFDDI meeting held in September 2013.
McCleary is a graduate of the University of North Carolina at Chapel Hill.